Depression Clinical Trials in Chicago

Showing 121-140 of 271 trials

IntelliCare in College Students - Implementation (ICCS-I)

NCT04108429

This study is a hybrid effectiveness-implementation trial of the smartphone student stress-management app IntelliCare for college students. This intervention will be tested with University of Illinois at Chicago (UIC) and Northern Illinois University (NIU) students. During the study, participants will complete measures of depressive and anxious symptoms, as well as measures of mental health literacy, within the app.

DepressionAnxiety

Northwestern University117 participantsStarted Feb 2020

Chicago, Illinois, United States

COMPLETED2.2 miles

COVID-19-Related Health and Practices Among Dental Hygienists

NCT04542915

As dental practices reopen their practices during a global pandemic, the risk of 2019 novel coronavirus (COVID-19) infection that dental hygienists face in providing dental care remains unknown. Estimating the occupational risk of COVID-19, and producing evidence on the types of infection control practices and dental practices that may affect COVID-19 risk, is therefore imperative. These findings could be used to describe the prevalence and incidence of COVID-19 among dental hygienists, determine what infection control steps dental hygienists take over time, describe dental hygienists' employment during the COVID-19 pandemic, and estimate whether infection control adherence in dental practice is related to COVID-19 incidence.

SARS-CoV InfectionAnxietyDepression+3 more

American Dental Association6,976 participantsStarted Sep 2020

Chicago, Illinois, United States

COMPLETEDNA2.2 miles

Evaluation of Text Message Engagement Support of Mindfulness Smartphone Applications

NCT03633682

The aim of this study is to assess the usability of two mindfulness smartphone applications (apps) and to evaluate whether text message support can promote engagement with those apps through a 4-week trial comparing support vs. no support.

DepressionAnxiety

Northwestern University40 participantsStarted Jun 2018

Chicago, Illinois, United States

IntelliCare in College Students - Implementation (ICCS-I)

COVID-19-Related Health and Practices Among Dental Hygienists

Evaluation of Text Message Engagement Support of Mindfulness Smartphone Applications

Depression Trials in Other Cities

SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study

Using CBT to Probe Psychobiobehavioral Resilience to Post-trauma Psychopathology

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIV

An Expert System to Reduce Depression in Primary Care

Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)

A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression

Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

rTMS for Depressed Teens: A Sham-Controlled Trial, Part 1

rTMS for Depressed Teens: A Sham-Controlled Trial, Part 2

Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant

Assessing Symptomatic Clinical Episodes in Depression

Other Conditions in Chicago